RE:RE:Chinese partner I think Beigene are seen by some as the most likely to become a global Pharma company. Something from China to eventually compete with the Pfizers of this world. Many seem to see them as the most legitimate of the up-and-coming Chinese biotech. It would be about as good as it could be to have them onboard. I'm going to say I'll remain sceptical until something materializes. It's likely just a guy following an industry leader in China.
SPCEO1 wrote: Nice find!
BGNE is a cancer focused company listed on NASDAQ, headquartered in Beijing and has a $25 billion market cap.It has $3.9 bilion in cash but is burning through that reasonably quickly ($888 million cash burn in the last twelve months).
Its stock is covered by 17 brokers including virtually all the top tier brokers.
BGNE would be able to easily sign a partnership deal for a meaningful amount of money with TH. Now, the question is what would be the potential scope of any such deal?
Bucknelly21 wrote: Looking at linkden this morning, Paul looks to be connected to a company called beigene, could this be a possible partner?